Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients.
Zweifel M, Thürlimann B, Riniker S, Weder P, von Moos R, Pagani O, Bigler M, Rothgiesser KM, Pilop C, Hawle H, Brauchli P, Tapia C, Schoenfeld W, Sessa C; Swiss Group for Clinical Cancer Research (SAKK).
Zweifel M, et al. Among authors: von moos r.
Endocr Connect. 2017 Oct;6(7):549-556. doi: 10.1530/EC-17-0174. Epub 2017 Aug 16.
Endocr Connect. 2017.
PMID: 28814476
Free PMC article.